RVMD EPS (Diluted) History: $-5.95 (FY2025)

Fiscal year	Q1	Q2	Q3	Q4
FY26	−$2.29−102.7%	−$3.06−133.6%	Not reported	Not reported
FY25	−$1.13−61.4%	−$1.31−61.7%	−$1.61−71.3%	Not reported
FY24	−$0.70+2.8%	−$0.81+12.0%	−$0.94+5.1%	Not reported
FY23	−$0.72+7.7%	−$0.92−12.2%	−$0.99−13.8%	Not reported
FY22	−$0.78	−$0.82−36.7%	−$0.87−20.8%	Not reported

01—History

EPS (Diluted) History

Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.

−$5.95

YoY changeLargest recent move−27.9%in FY21Latest −66.2%

02—Ledger

EPS (Diluted), period by period

Period	Value	Change	Source
FY2025	−$5.95	−66.2%	10-K
FY2024	−$3.58	+7.3%	10-K
FY2023	−$3.86	−25.3%	10-K
FY2022	−$3.08	−19.8%	10-K
FY2021	−$2.57	−27.9%	10-K
FY2020	−$2.01	—	10-K

03—Questions

What is eps (diluted)?

Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.

What is Revolution Medicines's current eps (diluted)?

Revolution Medicines (RVMD) annual eps (diluted) for 2025 was $-5.95, a 66.20% decline from 2024. Revolution Medicines eps (diluted) for the quarter ending June 30, 2026 was $-3.06.

What was Revolution Medicines's eps (diluted) in 2024?

Revolution Medicines annual eps (diluted) for 2024 was $-3.58, a 7.25% increase from 2023.

What was Revolution Medicines's eps (diluted) in 2023?

Revolution Medicines annual eps (diluted) for 2023 was $-3.86, a 25.32% decline from 2022.

Company: Revolution Medicines
Ticker: RVMD
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Revolution Medicines EPS (Diluted) 2020-2026 | RVMD

Key Statistics